Pharmacogenomics: How Your Genes Affect Your Response to Medications

Pharmacogenomics—the study of how an individual's genetic makeup affects their response to medications—is transforming personalized medicine. Understanding the genetic variations that affect drug metabolism, efficacy, and toxicity allows clinicians to tailor drug selection and dosing to individual patients.

How Genes Affect Drug Response

Drug response is affected by genetic variations at multiple levels. Drug-metabolizing enzymes determine how quickly drugs are broken down. Genetic variants in CYP450 enzymes (particularly CYP2D6, CYP2C19, and CYP2C9) are among the most clinically relevant. Poor metabolizers lack functional enzyme copies and accumulate drugs to toxic levels. Ultra-rapid metabolizers have extra gene copies and metabolize drugs so quickly they may not achieve therapeutic concentrations.

Drug transporters (like SLCO1B1 affecting statin uptake into liver cells) also affect drug distribution and elimination. Drug targets themselves can vary genetically—variations in the beta-2 adrenergic receptor gene (ADRB2) affect bronchodilator response in asthma, for example.

Clinically Actionable Pharmacogenomic Relationships

Several pharmacogenomic relationships are sufficiently well-established to guide clinical prescribing. Clopidogrel (Plavix) requires CYP2C19-mediated activation to its active antiplatelet form—CYP2C19 poor metabolizers receive inadequate antiplatelet effect and face higher cardiovascular risk. Alternative antiplatelet agents are recommended for these patients. Codeine is converted to morphine by CYP2D6—ultra-rapid metabolizers face potentially fatal morphine toxicity. Codeine is contraindicated in these patients and in children. Warfarin dosing is affected by variants in CYP2C9 (metabolism) and VKORC1 (target)—pharmacogenomic dosing algorithms incorporate these variants to reduce bleeding risk.

The Future of Pharmacogenomics

As genetic testing becomes cheaper and more accessible, pre-emptive pharmacogenomic testing—analyzing a patient's pharmacogenomic profile before they need specific medications—is gaining traction. Several health systems now incorporate pharmacogenomic data into electronic health records, providing point-of-care decision support when relevant medications are prescribed.

For more on human genetics and personalized medicine, visit our blog.